Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial

Abstract

BACKGROUND This study is a pre-registration trial of generic duloxetine that was approved by the China Food and Drug Administration (approval number: 2006L01603). AIMS Compare the treatment efficacy and safety of generic duloxetine to that of paroxetine in patients with major depressive disorders (MDD). METHODS This was a double-dummy, double-blind… (More)
DOI: 10.11919/j.issn.1002-0829.215064

Topics

5 Figures and Tables